Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8927)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 18, 2017 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Miozzo SAS, John JA, Appel-da-Silva MC, Dossin IA, Tovo CV, Mattos AA. Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis. World J Hepatol 2017; 9(35): 1278-1285 [PMID: 29290909 DOI: 10.4254/wjh.v9.i35.1278] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i35/1278.htm |
| Number | Citing Articles |
| 1 |
Sophie Ribiere, Marie-Anne Guillaumot, Amélie Barré, Einas Abou Ali, Maximilien Barret, Stanislas Chaussade, Romain Coriat. Quel est le VRAI risque au long cours des inhibiteurs de la pompe à protons ?. La Presse Médicale 2019; 48(5): 503 doi: 10.1016/j.lpm.2019.02.011
|
| 2 |
Raquel de Oliveira Coberllini JACQUES, Lais da Silva MASSIGNAN, Martina Schumacher WINKLER, Rafael Sartori BALBINOT, Silvana Sartori BALBINOT, Jonathan SOLDERA. ACUTE-ON-CHRONIC LIVER FAILURE IS INDEPENDENTLY ASSOCIATED WITH LOWER SURVIVAL IN PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS. Arquivos de Gastroenterologia 2021; 58(3): 344 doi: 10.1590/s0004-2803.202100000-58
|
| 3 |
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 2022; 23(4): 196 doi: 10.1111/1751-2980.13093
|
| 4 |
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología (English Edition) 2022; 45(1): 25 doi: 10.1016/j.gastre.2021.02.009
|
| 5 |
Angelo A. Mattos, Denusa Wiltgen, Raquel F. Jotz, Caroline M.R. Dornelles, Matheus V. Fernandes, Ângelo Z. Mattos. Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis. Annals of Hepatology 2020; 19(5): 451 doi: 10.1016/j.aohep.2020.04.010
|
| 6 |
Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee. High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study. Alimentary Pharmacology & Therapeutics 2024; 59(8): 973 doi: 10.1111/apt.17909
|
| 7 |
Zhen Yu Wong, Jia Hong Koh, Mark Muthiah, Benjamin Koh, Elden Yen Hng Ong, Christen En Ya Ong, Kai Qi Ou, Wen Hui Lim, Darren Jun Hao Tan, Douglas Chee, Kewin Tien Ho Siah, Yujun Wong, Apichat Kaewdech, Karn Wijarnpreecha, Anand V. Kulkarni, Benjamin Nah, Daniel Q. Huang, Mazen Noureddin, Cheng Han Ng, Margaret Teng. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis. Digestive Diseases and Sciences 2024; 69(1): 289 doi: 10.1007/s10620-023-08150-6
|
| 8 |
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología 2022; 45(1): 25 doi: 10.1016/j.gastrohep.2021.02.007
|
| 9 |
Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, Abdul Rehman Zia Zaidi, Ali A. Rabaan, Alyaa Elhazmi, Awad Al-Omari. Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00414-8
|
| 10 |
Lin Lin, Lijun Hou, You Deng, Tianming Zhao, Bangmao Wang, Chao Sun. Acid suppression therapy and its association with spontaneous bacterial peritonitis incidence: A systemic review and meta‐analysis. Hepatology Research 2020; 50(2): 233 doi: 10.1111/hepr.13447
|
| 11 |
Bo Tu, Yue-Ning Zhang, Jing-Feng Bi, Zhe Xu, Peng Zhao, Lei Shi, Xin Zhang, Guang Yang, En-Qiang Qin. Multivariate predictive model for asymptomatic spontaneous bacterial peritonitis in patients with liver cirrhosis. World Journal of Gastroenterology 2020; 26(29): 4316-4326 doi: 10.3748/wjg.v26.i29.4316
|
| 12 |
Xiaoli Wu, Daofu Zhang, Yuexiao Yu, Lianqing Lou, Xiaofei Li. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20193890
|
| 13 |
Amandeep Singh, Gail A. Cresci, Donald F. Kirby. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome. Nutrition in Clinical Practice 2018; 33(5): 614 doi: 10.1002/ncp.10181
|
| 14 |
Shih‐Lun Teng, Che‐Han Hsu, Chia‐Chun Hsu, Jeng‐Shiann Shin, Jen‐Chieh Huang. Association of gastric acid suppressants with the development of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Advances in Digestive Medicine 2020; 7(3): 139 doi: 10.1002/aid2.13164
|
| 15 |
Meng Zhang, Wei Liu, Xin Xu, Tao Chen, Jun-ying Qi. Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review. Current Medical Science 2022; 42(4): 673 doi: 10.1007/s11596-022-2607-3
|
| 16 |
Moloud Balafar, Morteza Ghojazadeh, Kavous Shahsavarinia, Zahra Parsian, Saba Hamedani, Hassan Soleimanpour. Association Between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis or Hepatic Encephalopathy in Cirrhotic Patients: A Systematic Review and Meta-analysis. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-132642
|
| 17 |
Abdel-Naser Elzouki, Nadia Neffati, Fatma A. Rasoul, Ali Abdallah, Muftah Othman, Abdelkarim Waness. Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using Proton Pump Inhibitors. GE - Portuguese Journal of Gastroenterology 2019; 26(2): 83 doi: 10.1159/000487963
|